Cannabinoid Pathway Mapping

Cannabinoid pathway mapping refers to the genetic and biochemical characterization of how cannabis plants synthesize cannabinoids—primarily THC and CBD—through enzymatic cascades. Breeders and researchers use pathway mapping to understand the genetic loci, enzyme variants, and environmental factors that determine cannabinoid ratios and minor compound expression. This classification framework helps distinguish between strains that produce THC-dominant, CBD-dominant, or balanced cannabinoid profiles based on the presence of key enzymes like THCA synthase and CBDA synthase. Pathway mapping is essential for targeted breeding programs seeking to stabilize specific cannabinoid ratios or unlock novel minor cannabinoid production. Understanding these biochemical routes informs seed selection, breeding strategy optimization, and preservation of desirable genetic traits across generations.

Breeders leverage cannabinoid pathway mapping to create predictable offspring ratios and develop stable F1 hybrids with defined cannabinoid profiles. Mapping also supports the isolation and stabilization of rare cannabinoid producers (CBG-dominant, CBDV-expressing lines, etc.) through marker-assisted selection and phenotype tracking.